Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus
- PMID: 29385873
- DOI: 10.1080/14397595.2018.1436028
Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus
Abstract
Objectives: TRIM21 is an E3 ubiquitin ligase for interferon regulatory factors (IRFs) that are involved in innate and acquired immunity. Here, we evaluated the role of TRIM21 in the interferon (IFN) signature of systemic lupus erythematosus (SLE).
Methods: Twenty SLE patients and 24 healthy controls were enrolled in this study. We analyzed mRNA expression of TRIM21, type I IFN, and IFN-inducible genes in peripheral blood mononuclear cell (PBMC). The protein levels of IRFs were assessed by Western blotting in PBMCs cultured with or without MG-132.
Results: The expression of TRIM21 mRNA and protein was significantly higher in SLE PBMCs as compared to healthy controls. There was a correlation between TRIM21 mRNA expression and SLE activities. In contrast to a negative correlation between mRNA expression level of TRIM21 and those of type I IFNs in healthy controls, we found a positive correlation between them in anti-TRIM21 antibody-positive SLE patients. Neither positive nor negative correlation was observed in the autoantibody-negative SLE patients. Western-blotting analysis revealed impaired ubiquitin-dependent proteasomal degradation of IRFs in SLE PBMCs.
Conclusion: Our study showed ubiquitin-dependent proteasomal degradation of IRFs was impaired in anti-TRIM21 antibody-dependent and -independent fashions, leading to amplification of IFN signature in SLE.
Keywords: E3 ubiquitin ligase; IRF; TRIM21; interferon signature; systemic lupus erythematosus.
Similar articles
-
Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors.J Immunol. 2013 Oct 1;191(7):3753-63. doi: 10.4049/jimmunol.1202341. Epub 2013 Aug 23. J Immunol. 2013. PMID: 23975864
-
Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus.Lupus. 2021 Nov;30(13):2054-2065. doi: 10.1177/09612033211042293. Epub 2021 Sep 25. Lupus. 2021. PMID: 34565210
-
Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.Arthritis Rheum. 2004 Dec;50(12):3958-67. doi: 10.1002/art.20798. Arthritis Rheum. 2004. PMID: 15593221
-
Interferon regulatory factors in human lupus pathogenesis.Transl Res. 2011 Jun;157(6):326-31. doi: 10.1016/j.trsl.2011.01.006. Epub 2011 Feb 8. Transl Res. 2011. PMID: 21575916 Free PMC article. Review.
-
[Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Dec 18;48(6):1100-1104. Beijing Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 27987522 Review. Chinese.
Cited by
-
An integrative Bayesian network approach to highlight key drivers in systemic lupus erythematosus.Arthritis Res Ther. 2020 Jun 23;22(1):156. doi: 10.1186/s13075-020-02239-3. Arthritis Res Ther. 2020. PMID: 32576231 Free PMC article.
-
TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis.Front Immunol. 2020 Feb 7;11:98. doi: 10.3389/fimmu.2020.00098. eCollection 2020. Front Immunol. 2020. PMID: 32117252 Free PMC article.
-
Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases.Front Immunol. 2024 Aug 6;15:1435525. doi: 10.3389/fimmu.2024.1435525. eCollection 2024. Front Immunol. 2024. PMID: 39165359 Free PMC article. Review.
-
Deubiquitylating enzymes: potential target in autoimmune diseases.Inflammopharmacology. 2021 Dec;29(6):1683-1699. doi: 10.1007/s10787-021-00890-z. Epub 2021 Nov 18. Inflammopharmacology. 2021. PMID: 34792672 Review.
-
TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease.Front Immunol. 2021 Sep 6;12:738473. doi: 10.3389/fimmu.2021.738473. eCollection 2021. Front Immunol. 2021. PMID: 34552597 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical